| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |